Dr. David A. Sinclair is a professor of genetics at Harvard Medical School and one of the most visible scientists in longevity research. His work has helped push aging biology into the public conversation, especially the ideas that cells lose important regulatory information over time and that some age-related changes may be reversible.
October 2026 update: interventions and epigenetic clocks
A 2026 peer-reviewed review coauthored by Sinclair examined 41 human studies in which an intervention changed—or failed to change—at least one newer epigenetic aging clock. The authors reported clock decreases in studies of interventions ranging from exercise and plant-rich diets to semaglutide, calorie restriction, omega-3 fatty acids and several pharmaceuticals. In the studies they reviewed, nicotinamide riboside, rapamycin and senolytics did not show a detectable clock effect.
This does not establish that the interventions with lower clock scores extend life, and it does not prove that interventions without a clock effect are ineffective for their approved medical uses. The underlying studies used different populations, durations, interventions and clock algorithms. A methylation-clock change is an investigational biomarker—not direct evidence of fewer heart attacks, less dementia, greater physical function or longer survival.
The review is useful because it organizes a fast-growing human evidence base and reinforces an important lesson: biological-age tests can generate hypotheses, but they cannot yet serve as a universal scorecard for whether a longevity treatment works.
What Sinclair’s lab is working on
1. Epigenetic information and aging
Your DNA sequence is only part of the biological story. Cells also use an epigenetic control system—chemical marks and structural cues that help determine which genes are active. Sinclair’s “information theory of aging” proposes that cellular stress and DNA repair gradually disrupt this control system, causing cells to lose aspects of their identity and function.
In a 2023 Cell study, researchers created controlled DNA breaks in mice without changing the DNA sequence. The mice developed molecular and physical signs associated with aging. Activating three reprogramming factors—Oct4, Sox2, and Klf4, often shortened to OSK—reversed some of those changes. This supports the hypothesis in that experimental model; it does not establish that epigenetic information loss is the sole cause of human aging.
2. Partial cellular reprogramming
Full reprogramming can return a mature cell to a stem-cell-like state, which would erase the cell’s useful identity and can create serious safety problems. Partial reprogramming aims to restore more youthful gene regulation without pushing the cell that far backward.
In a 2020 Nature paper, Sinclair and collaborators delivered OSK genes to retinal ganglion cells in mice. The intervention restored younger DNA-methylation patterns, promoted nerve regeneration after injury, and improved vision in mouse models of glaucoma and age-related vision loss. That is an important proof of concept—but it was a targeted gene-therapy experiment in mice, not a whole-body anti-aging treatment in people.
3. NAD, sirtuins, and cellular stress defenses
Sinclair’s earlier work centered on sirtuins, enzymes involved in metabolism, DNA repair, and cellular stress responses. Sirtuins depend on nicotinamide adenine dinucleotide, or NAD, a molecule involved in energy metabolism. His lab continues to study compounds that influence sirtuins and ways to raise cellular NAD levels.
A small 90-day randomized trial coauthored by Sinclair tested an experimental NAD precursor, MIB-626, in overweight or obese middle-aged and older adults. It increased circulating NAD and changed several secondary measures. The study was not evidence that NMN slows aging, prevents disease, or extends human life. Results for one proprietary compound also should not be generalized to every over-the-counter “NAD booster.”
4. Mitochondria and the aging brain
The lab also studies why communication between the nucleus and mitochondria deteriorates with age, how mitochondrial NAD may affect cell survival, and which genes regulate mitochondrial function. Current projects apply genetic models and molecular profiling to age-related neurodegeneration and memory loss.
What has—and has not—been demonstrated
| Claim | Evidence today |
|---|---|
| Epigenetic disruption can drive aging-like changes | Supported in a controlled mouse model; its role and relative importance in human aging remain under study. |
| Partial reprogramming can restore function | Promising results in mouse eye and nerve models. Human safety, durability, dosing, and clinical benefit are not established. |
| Raising NAD improves human longevity | Some short trials show that compounds can raise NAD and affect biomarkers. No trial has shown a longer human lifespan. |
| Resveratrol is a proven anti-aging treatment | No. Mechanistic and preclinical interest has not translated into proof that it extends healthy human life. |
| A biological-age test tells you how long you will live | No. Epigenetic clocks can be useful research tools, but a changing score is not the same as proven disease prevention or added years of life. |
Why the excitement needs guardrails
Reprogramming affects the machinery that controls cell identity. The same power that makes it scientifically exciting also creates concerns about unwanted cell growth, loss of identity, immune effects, and delivering the right dose to the right tissue. Long follow-up will be essential.
There is also a commercial layer. The Sinclair Lab states that its members have helped form numerous biotechnology companies. Several publications disclose patents, equity, advisory roles, or company relationships. Those interests do not invalidate the science, but they are a reason to read methods, endpoints, replication, and conflict disclosures—not only headlines or podcast claims.
What this means for you after 50
Follow the research, but do not treat early-stage biology as a personal protocol. There is currently no Sinclair-inspired stack proven to extend human life. NMN and resveratrol can also add cost, uncertainty, and possible interactions without solving the health risks most likely to shorten your healthy years.
The highest-confidence longevity work remains less futuristic: preserve muscle and power, build aerobic fitness, manage blood pressure and cholesterol, avoid tobacco, sleep consistently, maintain vaccination and screening, and work with a clinician on individual risks. Those actions may sound ordinary. Their evidence is anything but.
Frequently asked questions
Is David Sinclair a medical doctor?
No. He holds a Ph.D. and is a professor of genetics, not a physician. “Dr.” refers to his doctoral degree.
Does David Sinclair’s research prove aging can be reversed?
It shows that certain aging-associated molecular patterns and functions can be reversed in specific experimental systems, particularly mice. It does not yet prove that whole-body human aging can be safely reversed.
Should I take NMN or resveratrol?
Neither is proven to extend human lifespan. Discuss any supplement with a qualified clinician, especially if you take medication, have a medical condition, or are preparing for surgery.
Primary and institutional sources
- Sinclair Lab at Harvard Medical School: current research
- Harvard Medical School: David Sinclair biography
- Yang et al., Cell (2023): Loss of epigenetic information as a cause of mammalian aging
- Lu et al., Nature (2020): Reprogramming to recover youthful epigenetic information and restore vision
- Pencina et al. (2023): NAD augmentation in middle-aged and older adults
- Johnson and Sinclair (2026): Interventions that affect next-generation epigenetic aging clocks
Reviewed and updated October 1, 2026. This article is educational and does not provide medical advice.